Ionis Pharmaceuticals IONS Effective Income Tax Rate Reconciliation Orphan Drug Tax Credits Percent
Effective Income Tax Rate Reconciliation Orphan Drug Tax Credits Percent at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:EffectiveIncomeTaxRateReconciliationOrphanDrugTaxCreditsPercent.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's effective income tax rate reconciliation orphan drug tax credits percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's effective income tax rate reconciliation orphan drug tax credits percent?
- Ionis Pharmaceuticals (IONS) reported effective income tax rate reconciliation orphan drug tax credits percent of -8% in Q4 2025.
- What does effective income tax rate reconciliation orphan drug tax credits percent mean?
- The percentage point reduction in the effective tax rate due to orphan drug tax credits.
- How do you interpret effective income tax rate reconciliation orphan drug tax credits percent?
- An increase indicates that orphan drug incentives are playing a larger role in optimizing the company's tax position.
- How does effective income tax rate reconciliation orphan drug tax credits percent compare across companies?
- Used by investors to gauge the tax-related benefits of a company's rare disease portfolio.